SCHEMBL1002641

SCHEMBL1002641

O=Nc1ccc(O)c(F)c1O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PIM1 P11309 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRB2 P07550 1/20 0.31
ADRA1B P35368 1/20 0.31
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3078639 0.78 MAPT (0.42) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL3087121 0.77 ALDH1A1 (0.39) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL2602613 0.74 MAPT (0.40) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL9296302 0.73 RPS6KA3 (0.42) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL2914893 0.70 TDP1 (0.44) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL13123414 0.70 MEP1B (0.34) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL589864 0.70 MAPT (0.41) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL12955990 0.69 TDP1 (0.42) KDM4ENPC1ALDH1A1MAPTXBP1
SCHEMBL12580523 0.68 ALB (0.47) KDM4ENPC1MAPTL3MBTL1HSP90AA1
SCHEMBL13607302 0.68 CA3 (0.44) KDM4ENPC1ALDH1A1MAPTXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298312-B1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide MOLECULAR PROBES INC (US) 2018-09-26 EP disclosed
US-20170037248-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation 2017-02-09 US disclosed
US-20170037248-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation 2017-02-09 US disclosed
US-20170037248-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation 2017-02-09 US disclosed
US-9212385-B2 Fluorinated resorufin compounds and their application Life Technologies Corporation (US) 2015-12-15 US disclosed
US-9212385-B2 Fluorinated resorufin compounds and their application Life Technologies Corporation (US) 2015-12-15 US disclosed
EP-1685117-B1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE LIFE TECHNOLOGIES CORP (US) 2015-01-07 EP disclosed
US-20140220612-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation (US) 2014-08-07 US disclosed
US-20140220612-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation (US) 2014-08-07 US disclosed
US-20140220612-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation (US) 2014-08-07 US disclosed
US-7601851-B2 Compounds and methods for fluorescent labeling EPOCH BIOSCIENCES, INC. (US) 2009-10-13 US disclosed
US-7432372-B2 for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays INVITROGEN CORPORATION (US) 2008-10-07 US disclosed
US-7432372-B2 for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays INVITROGEN CORPORATION (US) 2008-10-07 US disclosed
US-7432372-B2 for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays INVITROGEN CORPORATION (US) 2008-10-07 US disclosed
US-20080113341-A1 Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays INVITROGEN CORPORATION (US) 2008-05-15 US disclosed
US-20080113341-A1 Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays INVITROGEN CORPORATION (US) 2008-05-15 US disclosed
US-20080113341-A1 Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays INVITROGEN CORPORATION (US) 2008-05-15 US disclosed
EP-1685117-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE Molecular Probes Inc. (US) 2006-08-02 EP disclosed
WO-2005042504-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE MOLECULAR PROBES, INC. (US) 2005-05-12 WO disclosed
US-20050096315-A1 for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays Life Technologies Corporation 2005-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037248-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION CYP2F1, CYP4F2, CYP4F3 KDM4E 2370/4885NPC1 195/4885ALDH1A1 162/4885
US-20050096315-A1 for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays GPX4, PRDX3, MPO KDM4E 4139/4885NPC1 3248/4885ALDH1A1 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.